Use of Clarithromycin and Adverse Cardiovascular Events among Older Patients Receiving Donepezil View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2012-03

AUTHORS

Janine R. Hutson, Hadas D. Fischer, Xuesong Wang, Andrea Gruneir, Nick Daneman, Sudeep S. Gill, Paula A. Rochon, Geoffrey M. Anderson

ABSTRACT

BACKGROUND: Donepezil is a commonly used drug in older people that due to its procholinergic effects can provoke bradycardia and neurocardiogenic syncope. Donepezil is metabolized by the cytochrome P450 isozyme 3A4 (CYP3A4). Clarithromycin is a potent inhibitor of CYP3A4, and patients taking both of these drugs may be at increased risk of cardiac adverse events. OBJECTIVE: The aim of this study was to evaluate the association between recent use of clarithromycin and adverse cardiovascular events in elderly patients receiving donepezil. METHODS: A population-based, nested case-control study using provincial healthcare databases was conducted. The base cohort was made up of persons 66 years of age or older who were prescribed donepezil and also were prescribed clarithromycin, erythromycin, azithromycin, cefuroxime, moxifloxacin or levofloxacin. Cases were those members of the base cohort hospitalized for bradycardia, syncope or complete atrioventricular block. For each case patient, five controls were matched according to age, sex and residence (community or long-term care). RESULTS: Between July 2002 and March 2010, 17,712 patients continuously receiving donepezil were prescribed one of the antibacterials. In 1400 person-years of follow-up, 59 cases were identified. As compared with azithromycin, there was no statistically significant association between use of clarithromycin in donepezil users and subsequent adverse cardiovascular events (odds ratio 0.67; 95% CI 0.28, 1.63). There was no significant risk associated with exposure to either cefuroxime or respiratory quinolones. CONCLUSIONS: The use of clarithromycin in elderly donepezil users did not significantly increase the risk of adverse cardiovascular outcomes. However, our study cannot rule out a possible small increase in risk. Although antibacterials can be beneficial, care should be taken in selecting antibacterials for use in older people receiving donepezil. More... »

PAGES

205-211

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.2165/11599090-000000000-00000

DOI

http://dx.doi.org/10.2165/11599090-000000000-00000

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1009392785

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/22372724


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1117", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Public Health and Health Services", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged, 80 and over", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Anti-Bacterial Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Atrioventricular Block", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Bradycardia", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cardiovascular Diseases", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Case-Control Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cholinesterase Inhibitors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Clarithromycin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cohort Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cytochrome P-450 CYP3A Inhibitors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Interactions", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Prescriptions", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Enzyme Inhibitors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Indans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Macrolides", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Ontario", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Piperidines", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Syncope", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "University of Toronto", 
          "id": "https://www.grid.ac/institutes/grid.17063.33", 
          "name": [
            "Faculty of Medicine, University of Toronto, Toronto, ON, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hutson", 
        "givenName": "Janine R.", 
        "id": "sg:person.0653763073.75", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0653763073.75"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Sunnybrook Health Sciences Centre, Institute for Clinical Evaluative Sciences, Toronto, ON, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fischer", 
        "givenName": "Hadas D.", 
        "id": "sg:person.01144717762.18", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01144717762.18"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Sunnybrook Health Sciences Centre, Institute for Clinical Evaluative Sciences, Toronto, ON, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wang", 
        "givenName": "Xuesong", 
        "id": "sg:person.01056752152.84", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01056752152.84"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Toronto", 
          "id": "https://www.grid.ac/institutes/grid.17063.33", 
          "name": [
            "Sunnybrook Health Sciences Centre, Institute for Clinical Evaluative Sciences, Toronto, ON, Canada", 
            "Women\u2019s College Research Institute, Women\u2019s College Hospital, Toronto, ON, Canada", 
            "Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, ON, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gruneir", 
        "givenName": "Andrea", 
        "id": "sg:person.01234641247.26", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01234641247.26"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Sunnybrook Health Sciences Centre, Institute for Clinical Evaluative Sciences, Toronto, ON, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Daneman", 
        "givenName": "Nick", 
        "id": "sg:person.01364536725.09", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01364536725.09"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Queen's University", 
          "id": "https://www.grid.ac/institutes/grid.410356.5", 
          "name": [
            "Sunnybrook Health Sciences Centre, Institute for Clinical Evaluative Sciences, Toronto, ON, Canada", 
            "Department of Medicine, Queen\u2019s University, Kingston, ON, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gill", 
        "givenName": "Sudeep S.", 
        "id": "sg:person.01261146362.20", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01261146362.20"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Toronto", 
          "id": "https://www.grid.ac/institutes/grid.17063.33", 
          "name": [
            "Faculty of Medicine, University of Toronto, Toronto, ON, Canada", 
            "Sunnybrook Health Sciences Centre, Institute for Clinical Evaluative Sciences, Toronto, ON, Canada", 
            "Women\u2019s College Research Institute, Women\u2019s College Hospital, Toronto, ON, Canada", 
            "Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, ON, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rochon", 
        "givenName": "Paula A.", 
        "id": "sg:person.01005772611.81", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01005772611.81"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Toronto", 
          "id": "https://www.grid.ac/institutes/grid.17063.33", 
          "name": [
            "Sunnybrook Health Sciences Centre, Institute for Clinical Evaluative Sciences, Toronto, ON, Canada", 
            "Women\u2019s College Research Institute, Women\u2019s College Hospital, Toronto, ON, Canada", 
            "Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, ON, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Anderson", 
        "givenName": "Geoffrey M.", 
        "id": "sg:person.013547764572.30", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013547764572.30"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1159/000068781", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002677138"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/archinternmed.2010.37", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008758374"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jjcc.2009.03.011", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009008299"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1086/313959", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015775451"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/pds.1746", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018332592"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/pds.1746", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018332592"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/ageing/afq158", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024045720"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa055191", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027423537"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00228-006-0168-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030133192", 
          "https://doi.org/10.1007/s00228-006-0168-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00228-006-0168-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030133192", 
          "https://doi.org/10.1007/s00228-006-0168-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1532-5415.2009.02488.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032550522"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1532-5415.2009.02488.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032550522"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1345/aph.1l432", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033480476"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1345/aph.1l432", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033480476"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1046/j.1525-1497.2001.016006376.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034909896", 
          "https://doi.org/10.1046/j.1525-1497.2001.016006376.x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1503/cmaj.100702", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037966301"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1503/cmaj.100702", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037966301"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00228-005-0946-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038725195", 
          "https://doi.org/10.1007/s00228-005-0946-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00228-005-0946-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038725195", 
          "https://doi.org/10.1007/s00228-005-0946-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00228-005-0946-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038725195", 
          "https://doi.org/10.1007/s00228-005-0946-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/archinternmed.2009.43", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039314358"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1371/journal.pmed.1000157", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042241562"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/clpt.2009.127", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049257231", 
          "https://doi.org/10.1038/clpt.2009.127"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1046/j.1365-2125.1998.0460s1025.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1056732607"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1046/j.1365-2125.1998.0460s1030.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1056732608"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2012-03", 
    "datePublishedReg": "2012-03-01", 
    "description": "BACKGROUND: Donepezil is a commonly used drug in older people that due to its procholinergic effects can provoke bradycardia and neurocardiogenic syncope. Donepezil is metabolized by the cytochrome P450 isozyme 3A4 (CYP3A4). Clarithromycin is a potent inhibitor of CYP3A4, and patients taking both of these drugs may be at increased risk of cardiac adverse events.\nOBJECTIVE: The aim of this study was to evaluate the association between recent use of clarithromycin and adverse cardiovascular events in elderly patients receiving donepezil.\nMETHODS: A population-based, nested case-control study using provincial healthcare databases was conducted. The base cohort was made up of persons 66 years of age or older who were prescribed donepezil and also were prescribed clarithromycin, erythromycin, azithromycin, cefuroxime, moxifloxacin or levofloxacin. Cases were those members of the base cohort hospitalized for bradycardia, syncope or complete atrioventricular block. For each case patient, five controls were matched according to age, sex and residence (community or long-term care).\nRESULTS: Between July 2002 and March 2010, 17,712 patients continuously receiving donepezil were prescribed one of the antibacterials. In 1400 person-years of follow-up, 59 cases were identified. As compared with azithromycin, there was no statistically significant association between use of clarithromycin in donepezil users and subsequent adverse cardiovascular events (odds ratio 0.67; 95% CI 0.28, 1.63). There was no significant risk associated with exposure to either cefuroxime or respiratory quinolones.\nCONCLUSIONS: The use of clarithromycin in elderly donepezil users did not significantly increase the risk of adverse cardiovascular outcomes. However, our study cannot rule out a possible small increase in risk. Although antibacterials can be beneficial, care should be taken in selecting antibacterials for use in older people receiving donepezil.", 
    "genre": "research_article", 
    "id": "sg:pub.10.2165/11599090-000000000-00000", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1100990", 
        "issn": [
          "1170-229X", 
          "1179-1969"
        ], 
        "name": "Drugs & Aging", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "3", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "29"
      }
    ], 
    "name": "Use of Clarithromycin and Adverse Cardiovascular Events among Older Patients Receiving Donepezil", 
    "pagination": "205-211", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "2cbe6e73eecccaaad6868c3c9cde97f0b22fa28068700b7dc2b67328a4aa8fc8"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "22372724"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "9102074"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.2165/11599090-000000000-00000"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1009392785"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.2165/11599090-000000000-00000", 
      "https://app.dimensions.ai/details/publication/pub.1009392785"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T21:41", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8687_00000536.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.2165%2F11599090-000000000-00000"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.2165/11599090-000000000-00000'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.2165/11599090-000000000-00000'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.2165/11599090-000000000-00000'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.2165/11599090-000000000-00000'


 

This table displays all metadata directly associated to this object as RDF triples.

277 TRIPLES      21 PREDICATES      69 URIs      43 LITERALS      31 BLANK NODES

Subject Predicate Object
1 sg:pub.10.2165/11599090-000000000-00000 schema:about N09c8bb6017b54cd8a7cb02d4f26141cd
2 N0aa462c9ed5f4b5e8b35f860e5995672
3 N15d0f43a04f348a284a9ea67e9cde885
4 N22136ea1177f47b6a7db1df08ce5d58c
5 N3bd2213f43cd4e4594fd1b2dded62d39
6 N4e60705ed3b740d4998206b39e24e3fc
7 N514ec78670f348b1932aa21be9b464b7
8 N5513921fa9ee4f6bbc43c956772a7c90
9 N5722996ef87741f0875afbf0dad981f0
10 N64d6f1297b194ea39e03a3d45d1da545
11 N67196d112da841ce8728c1922b3f8c4c
12 N6812042695864478912d3aa5793b4467
13 N6a1a35be1cd64001aa6fd3b0166bb3d2
14 N6c435f0516c141b88788da90db54bc98
15 N75803a7347f047a7950603c75e115421
16 N7651294fec2740388c9983da59e7feb7
17 N792afc101a6d4769aa7227504f796fa2
18 N816b61b3b1424187999711b846eeb072
19 Nb56323176e2142269d58338efd841797
20 Nb7e46397a7ee4e5799ec28939219c566
21 Nefe26ead9001444a9f7421e92f91cfa3
22 Nf7de64c9e037487e8796ee6bc7ebe8a5
23 anzsrc-for:11
24 anzsrc-for:1117
25 schema:author N65c859c5ba814ada8ccf2853723355da
26 schema:citation sg:pub.10.1007/s00228-005-0946-1
27 sg:pub.10.1007/s00228-006-0168-1
28 sg:pub.10.1038/clpt.2009.127
29 sg:pub.10.1046/j.1525-1497.2001.016006376.x
30 https://doi.org/10.1001/archinternmed.2009.43
31 https://doi.org/10.1001/archinternmed.2010.37
32 https://doi.org/10.1002/pds.1746
33 https://doi.org/10.1016/j.jjcc.2009.03.011
34 https://doi.org/10.1046/j.1365-2125.1998.0460s1025.x
35 https://doi.org/10.1046/j.1365-2125.1998.0460s1030.x
36 https://doi.org/10.1056/nejmoa055191
37 https://doi.org/10.1086/313959
38 https://doi.org/10.1093/ageing/afq158
39 https://doi.org/10.1111/j.1532-5415.2009.02488.x
40 https://doi.org/10.1159/000068781
41 https://doi.org/10.1345/aph.1l432
42 https://doi.org/10.1371/journal.pmed.1000157
43 https://doi.org/10.1503/cmaj.100702
44 schema:datePublished 2012-03
45 schema:datePublishedReg 2012-03-01
46 schema:description BACKGROUND: Donepezil is a commonly used drug in older people that due to its procholinergic effects can provoke bradycardia and neurocardiogenic syncope. Donepezil is metabolized by the cytochrome P450 isozyme 3A4 (CYP3A4). Clarithromycin is a potent inhibitor of CYP3A4, and patients taking both of these drugs may be at increased risk of cardiac adverse events. OBJECTIVE: The aim of this study was to evaluate the association between recent use of clarithromycin and adverse cardiovascular events in elderly patients receiving donepezil. METHODS: A population-based, nested case-control study using provincial healthcare databases was conducted. The base cohort was made up of persons 66 years of age or older who were prescribed donepezil and also were prescribed clarithromycin, erythromycin, azithromycin, cefuroxime, moxifloxacin or levofloxacin. Cases were those members of the base cohort hospitalized for bradycardia, syncope or complete atrioventricular block. For each case patient, five controls were matched according to age, sex and residence (community or long-term care). RESULTS: Between July 2002 and March 2010, 17,712 patients continuously receiving donepezil were prescribed one of the antibacterials. In 1400 person-years of follow-up, 59 cases were identified. As compared with azithromycin, there was no statistically significant association between use of clarithromycin in donepezil users and subsequent adverse cardiovascular events (odds ratio 0.67; 95% CI 0.28, 1.63). There was no significant risk associated with exposure to either cefuroxime or respiratory quinolones. CONCLUSIONS: The use of clarithromycin in elderly donepezil users did not significantly increase the risk of adverse cardiovascular outcomes. However, our study cannot rule out a possible small increase in risk. Although antibacterials can be beneficial, care should be taken in selecting antibacterials for use in older people receiving donepezil.
47 schema:genre research_article
48 schema:inLanguage en
49 schema:isAccessibleForFree false
50 schema:isPartOf Na30409aa7f364fa29d06012897959af4
51 Ncef3e5266aa4436c9086acd10d02a0fa
52 sg:journal.1100990
53 schema:name Use of Clarithromycin and Adverse Cardiovascular Events among Older Patients Receiving Donepezil
54 schema:pagination 205-211
55 schema:productId N0ea22ef633e74e13b9eb5e2d00edda03
56 N220bef9a6eee4236a166b686a84eda6b
57 N3549ce9840454a5b92c44f1b6b4ad39a
58 N54408c0c815844499f919df3a03ebe00
59 N98b7cf60071342c6b868239de6620e1f
60 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009392785
61 https://doi.org/10.2165/11599090-000000000-00000
62 schema:sdDatePublished 2019-04-10T21:41
63 schema:sdLicense https://scigraph.springernature.com/explorer/license/
64 schema:sdPublisher Nd0b9ad912e514439b98c4e505844eb55
65 schema:url http://link.springer.com/10.2165%2F11599090-000000000-00000
66 sgo:license sg:explorer/license/
67 sgo:sdDataset articles
68 rdf:type schema:ScholarlyArticle
69 N09c8bb6017b54cd8a7cb02d4f26141cd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
70 schema:name Atrioventricular Block
71 rdf:type schema:DefinedTerm
72 N0aa462c9ed5f4b5e8b35f860e5995672 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
73 schema:name Aged
74 rdf:type schema:DefinedTerm
75 N0c6a726d87c44de69e5c66c14260ea35 rdf:first sg:person.01144717762.18
76 rdf:rest N62f346014b8347b9a1b6148b19f05049
77 N0ea22ef633e74e13b9eb5e2d00edda03 schema:name nlm_unique_id
78 schema:value 9102074
79 rdf:type schema:PropertyValue
80 N15d0f43a04f348a284a9ea67e9cde885 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
81 schema:name Bradycardia
82 rdf:type schema:DefinedTerm
83 N16140f6b41fd46f093dc00a490489ed7 rdf:first sg:person.01364536725.09
84 rdf:rest N470a517a49d54fcc833cd42558bfb862
85 N220bef9a6eee4236a166b686a84eda6b schema:name doi
86 schema:value 10.2165/11599090-000000000-00000
87 rdf:type schema:PropertyValue
88 N22136ea1177f47b6a7db1df08ce5d58c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
89 schema:name Macrolides
90 rdf:type schema:DefinedTerm
91 N3218fcf404614d4c9d56161ef7c94fad rdf:first sg:person.01005772611.81
92 rdf:rest Nc36cc1b3a69a4c7f84cea767d9944cfe
93 N3549ce9840454a5b92c44f1b6b4ad39a schema:name dimensions_id
94 schema:value pub.1009392785
95 rdf:type schema:PropertyValue
96 N3bd2213f43cd4e4594fd1b2dded62d39 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
97 schema:name Ontario
98 rdf:type schema:DefinedTerm
99 N4536995645d14b4d85fb2caa4ec8def8 schema:name Sunnybrook Health Sciences Centre, Institute for Clinical Evaluative Sciences, Toronto, ON, Canada
100 rdf:type schema:Organization
101 N470a517a49d54fcc833cd42558bfb862 rdf:first sg:person.01261146362.20
102 rdf:rest N3218fcf404614d4c9d56161ef7c94fad
103 N4e60705ed3b740d4998206b39e24e3fc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
104 schema:name Aged, 80 and over
105 rdf:type schema:DefinedTerm
106 N514ec78670f348b1932aa21be9b464b7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name Humans
108 rdf:type schema:DefinedTerm
109 N54408c0c815844499f919df3a03ebe00 schema:name readcube_id
110 schema:value 2cbe6e73eecccaaad6868c3c9cde97f0b22fa28068700b7dc2b67328a4aa8fc8
111 rdf:type schema:PropertyValue
112 N5513921fa9ee4f6bbc43c956772a7c90 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
113 schema:name Cholinesterase Inhibitors
114 rdf:type schema:DefinedTerm
115 N5722996ef87741f0875afbf0dad981f0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
116 schema:name Syncope
117 rdf:type schema:DefinedTerm
118 N58ba2933ec8543fa931c76d320b5c029 rdf:first sg:person.01234641247.26
119 rdf:rest N16140f6b41fd46f093dc00a490489ed7
120 N61e8f3c56c26451e927ecab8c13f48a6 schema:name Sunnybrook Health Sciences Centre, Institute for Clinical Evaluative Sciences, Toronto, ON, Canada
121 rdf:type schema:Organization
122 N62f346014b8347b9a1b6148b19f05049 rdf:first sg:person.01056752152.84
123 rdf:rest N58ba2933ec8543fa931c76d320b5c029
124 N64d6f1297b194ea39e03a3d45d1da545 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Drug Interactions
126 rdf:type schema:DefinedTerm
127 N65c859c5ba814ada8ccf2853723355da rdf:first sg:person.0653763073.75
128 rdf:rest N0c6a726d87c44de69e5c66c14260ea35
129 N67196d112da841ce8728c1922b3f8c4c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Cardiovascular Diseases
131 rdf:type schema:DefinedTerm
132 N6812042695864478912d3aa5793b4467 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Drug Prescriptions
134 rdf:type schema:DefinedTerm
135 N6a1a35be1cd64001aa6fd3b0166bb3d2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Anti-Bacterial Agents
137 rdf:type schema:DefinedTerm
138 N6c435f0516c141b88788da90db54bc98 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Piperidines
140 rdf:type schema:DefinedTerm
141 N75803a7347f047a7950603c75e115421 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Cytochrome P-450 CYP3A Inhibitors
143 rdf:type schema:DefinedTerm
144 N7651294fec2740388c9983da59e7feb7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Cohort Studies
146 rdf:type schema:DefinedTerm
147 N792afc101a6d4769aa7227504f796fa2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Enzyme Inhibitors
149 rdf:type schema:DefinedTerm
150 N7b39848d99c8419a911adfcfc876c522 schema:name Sunnybrook Health Sciences Centre, Institute for Clinical Evaluative Sciences, Toronto, ON, Canada
151 rdf:type schema:Organization
152 N816b61b3b1424187999711b846eeb072 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name Indans
154 rdf:type schema:DefinedTerm
155 N98b7cf60071342c6b868239de6620e1f schema:name pubmed_id
156 schema:value 22372724
157 rdf:type schema:PropertyValue
158 Na30409aa7f364fa29d06012897959af4 schema:issueNumber 3
159 rdf:type schema:PublicationIssue
160 Nb56323176e2142269d58338efd841797 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
161 schema:name Female
162 rdf:type schema:DefinedTerm
163 Nb7e46397a7ee4e5799ec28939219c566 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
164 schema:name Clarithromycin
165 rdf:type schema:DefinedTerm
166 Nc36cc1b3a69a4c7f84cea767d9944cfe rdf:first sg:person.013547764572.30
167 rdf:rest rdf:nil
168 Ncef3e5266aa4436c9086acd10d02a0fa schema:volumeNumber 29
169 rdf:type schema:PublicationVolume
170 Nd0b9ad912e514439b98c4e505844eb55 schema:name Springer Nature - SN SciGraph project
171 rdf:type schema:Organization
172 Nefe26ead9001444a9f7421e92f91cfa3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
173 schema:name Case-Control Studies
174 rdf:type schema:DefinedTerm
175 Nf7de64c9e037487e8796ee6bc7ebe8a5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
176 schema:name Male
177 rdf:type schema:DefinedTerm
178 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
179 schema:name Medical and Health Sciences
180 rdf:type schema:DefinedTerm
181 anzsrc-for:1117 schema:inDefinedTermSet anzsrc-for:
182 schema:name Public Health and Health Services
183 rdf:type schema:DefinedTerm
184 sg:journal.1100990 schema:issn 1170-229X
185 1179-1969
186 schema:name Drugs & Aging
187 rdf:type schema:Periodical
188 sg:person.01005772611.81 schema:affiliation https://www.grid.ac/institutes/grid.17063.33
189 schema:familyName Rochon
190 schema:givenName Paula A.
191 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01005772611.81
192 rdf:type schema:Person
193 sg:person.01056752152.84 schema:affiliation N4536995645d14b4d85fb2caa4ec8def8
194 schema:familyName Wang
195 schema:givenName Xuesong
196 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01056752152.84
197 rdf:type schema:Person
198 sg:person.01144717762.18 schema:affiliation N7b39848d99c8419a911adfcfc876c522
199 schema:familyName Fischer
200 schema:givenName Hadas D.
201 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01144717762.18
202 rdf:type schema:Person
203 sg:person.01234641247.26 schema:affiliation https://www.grid.ac/institutes/grid.17063.33
204 schema:familyName Gruneir
205 schema:givenName Andrea
206 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01234641247.26
207 rdf:type schema:Person
208 sg:person.01261146362.20 schema:affiliation https://www.grid.ac/institutes/grid.410356.5
209 schema:familyName Gill
210 schema:givenName Sudeep S.
211 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01261146362.20
212 rdf:type schema:Person
213 sg:person.013547764572.30 schema:affiliation https://www.grid.ac/institutes/grid.17063.33
214 schema:familyName Anderson
215 schema:givenName Geoffrey M.
216 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013547764572.30
217 rdf:type schema:Person
218 sg:person.01364536725.09 schema:affiliation N61e8f3c56c26451e927ecab8c13f48a6
219 schema:familyName Daneman
220 schema:givenName Nick
221 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01364536725.09
222 rdf:type schema:Person
223 sg:person.0653763073.75 schema:affiliation https://www.grid.ac/institutes/grid.17063.33
224 schema:familyName Hutson
225 schema:givenName Janine R.
226 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0653763073.75
227 rdf:type schema:Person
228 sg:pub.10.1007/s00228-005-0946-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038725195
229 https://doi.org/10.1007/s00228-005-0946-1
230 rdf:type schema:CreativeWork
231 sg:pub.10.1007/s00228-006-0168-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030133192
232 https://doi.org/10.1007/s00228-006-0168-1
233 rdf:type schema:CreativeWork
234 sg:pub.10.1038/clpt.2009.127 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049257231
235 https://doi.org/10.1038/clpt.2009.127
236 rdf:type schema:CreativeWork
237 sg:pub.10.1046/j.1525-1497.2001.016006376.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1034909896
238 https://doi.org/10.1046/j.1525-1497.2001.016006376.x
239 rdf:type schema:CreativeWork
240 https://doi.org/10.1001/archinternmed.2009.43 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039314358
241 rdf:type schema:CreativeWork
242 https://doi.org/10.1001/archinternmed.2010.37 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008758374
243 rdf:type schema:CreativeWork
244 https://doi.org/10.1002/pds.1746 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018332592
245 rdf:type schema:CreativeWork
246 https://doi.org/10.1016/j.jjcc.2009.03.011 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009008299
247 rdf:type schema:CreativeWork
248 https://doi.org/10.1046/j.1365-2125.1998.0460s1025.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1056732607
249 rdf:type schema:CreativeWork
250 https://doi.org/10.1046/j.1365-2125.1998.0460s1030.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1056732608
251 rdf:type schema:CreativeWork
252 https://doi.org/10.1056/nejmoa055191 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027423537
253 rdf:type schema:CreativeWork
254 https://doi.org/10.1086/313959 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015775451
255 rdf:type schema:CreativeWork
256 https://doi.org/10.1093/ageing/afq158 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024045720
257 rdf:type schema:CreativeWork
258 https://doi.org/10.1111/j.1532-5415.2009.02488.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1032550522
259 rdf:type schema:CreativeWork
260 https://doi.org/10.1159/000068781 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002677138
261 rdf:type schema:CreativeWork
262 https://doi.org/10.1345/aph.1l432 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033480476
263 rdf:type schema:CreativeWork
264 https://doi.org/10.1371/journal.pmed.1000157 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042241562
265 rdf:type schema:CreativeWork
266 https://doi.org/10.1503/cmaj.100702 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037966301
267 rdf:type schema:CreativeWork
268 https://www.grid.ac/institutes/grid.17063.33 schema:alternateName University of Toronto
269 schema:name Faculty of Medicine, University of Toronto, Toronto, ON, Canada
270 Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, ON, Canada
271 Sunnybrook Health Sciences Centre, Institute for Clinical Evaluative Sciences, Toronto, ON, Canada
272 Women’s College Research Institute, Women’s College Hospital, Toronto, ON, Canada
273 rdf:type schema:Organization
274 https://www.grid.ac/institutes/grid.410356.5 schema:alternateName Queen's University
275 schema:name Department of Medicine, Queen’s University, Kingston, ON, Canada
276 Sunnybrook Health Sciences Centre, Institute for Clinical Evaluative Sciences, Toronto, ON, Canada
277 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...